相关实验视频

Updated: May 28, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

克洛托调节了慢性阻塞性肺病中俱乐部细胞衰老和分化

Min Li^1,2,3, Bo Chen^1,4,5, Sibo Sun⁶

¹Department of Geriatrics, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Cell proliferation

|February 11, 2025

概括

克洛托缺乏加剧慢性阻塞性肺病 (COPD) 通过加速细胞衰老和肺炎. 向缩可能会逆转肺老化和COPD中球状细胞衰老.

科学领域:

肺部医学肺部医学
衰老研究研究衰老研究
细胞生物学细胞生物学

背景情况:

慢性阻塞性肺病 (COPD) 涉及慢性炎症和细胞衰老.
俱乐部细胞及其分泌蛋白 (CCSP) 具有抗炎性质,在COPD中减弱.
在人类的COPD肺组织中,Klotho (KL) 水平降低,而在小鼠中,KL缺乏模仿了COPD类似的衰老表型.

研究的目的:

为了研究Klotho (KL),俱乐部细胞和COPD病原体之间的关系.
探索KL缺乏如何影响细胞衰老,并有助于COPD相关的炎症.

主要方法:

慢性肺炎肺组织的单细胞RNA测序 (scRNA-seq) 用于分析俱乐部细胞异质性和衰老.
在香烟烟雾 (CS) 诱导的COPD小鼠模型中分析KL和CCSP表达.
评估KL淘汰赛对细胞分化和肺炎的影响.
使用SA-β-gal染色进行体外研究,以评估hnRNPA2/B1和nedddylation在球体细胞衰老中的作用.

主要成果:

scRNA-seq揭示了COPD肺部的俱乐部细胞异质性和衰老.
在CS诱导的COPD小鼠中,KL和CCSP表达减少,与衰老标志物相关联.
KL 缺乏导致状细胞消失,状细胞增加,状细胞衰老加重,肺炎炎症恶化.
鉴定到 hnRNPA2/B1 是 KL 调节的俱乐部细胞衰老中的关键分子,而无化则影响了 hnRNPA2/B1 的水平.

结论:

克洛托 (KL) 调节了俱乐部细胞衰老和分化.
KL缺乏症会加剧肺炎和细胞衰老,以应对香烟烟雾,影响纤毛细胞的功能.
向缩呈现了一个潜在的治疗策略,用于逆转肺老化和COPD中球状细胞衰老.

关键词:

慢性阻塞性肺病慢性阻塞性肺病俱乐部细胞细胞俱乐部细胞克洛托托克 (klothootho) 是一个古老的语言.在 scRNA-seqq 中.衰老是一种老化.

更多相关视频

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry

Measurement of Protein Turnover Rates in Senescent and Non-Dividing Cultured Cells with Metabolic Labeling and Mass Spectrometry

Published on: April 6, 2022

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Published on: August 12, 2018

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...